Sage Therapeutics (SAGE) SEC Filings & 10K Form

$14.00
+1.05 (+8.11%)
(As of 11:36 AM ET)

Recent Sage Therapeutics SEC Filings

DateFilerForm TypeView
04/19/2024
7:31 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
5:35 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
7:34 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
6:20 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:09 AM
RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
Form SC 13G
02/14/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:13 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/13/2024
5:28 AM
Sage Therapeutics (Subject)
Form SC 13G/A
02/13/2024
5:28 AM
BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/08/2024
9:17 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/31/2024
4:25 PM
Sage Therapeutics (Subject)
Form SC TO-I/A
01/31/2024
3:50 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:04 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
7:13 AM
Sage Therapeutics (Subject)
Form SC TO-I
01/08/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
7:30 AM
Sage Therapeutics (Filer)
Form DEF 14A
12/19/2023
7:32 AM
Sage Therapeutics (Filer)
Form DEFA14A
12/08/2023
8:00 AM
Sage Therapeutics (Subject)
Form SC TO-C
12/08/2023
7:30 AM
Sage Therapeutics (Filer)
Form PRE 14A
12/08/2023
7:30 AM
Sage Therapeutics (Filer)
Form PRE 14A
11/07/2023
6:39 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:29 AM
Sage Therapeutics (Filer)
Form 424B5
11/07/2023
6:00 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
5:46 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
7:51 AM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2023
6:20 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
7:44 AM
Sage Therapeutics (Subject)
Form SC 13G/A
07/10/2023
7:44 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
05/11/2023
7:58 AM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:21 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2023
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Biden replacement revealed? (Ad)

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SAGE) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners